So the Committee just wanted a "second opinion" on Genasense's effectiveness? That would make sense.
So there was nothing wrong with the first trial results, but those results needed to be confirmed with another trial?
That makes sense. It's so hard to get to the bottom of these Press releases sometimes. Being a medical layman, I'm confused as to the procedure of bringing products to market.
Market Data 
Markets 
AI
